Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Combination treatment can provide long remissions for young patients with chronic lymphocytic leukemia

Combination treatment can provide long remissions for young patients with chronic lymphocytic leukemia

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

mRNA BNT162b2 vaccine safe in immunocompromised patients

mRNA BNT162b2 vaccine safe in immunocompromised patients

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Researchers develop a new way to tag tumor cells to understand cancer treatment resistance

Researchers develop a new way to tag tumor cells to understand cancer treatment resistance

Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

New integrative NGS panel for analysis of standard and novel biomarkers in lymphoid neoplasms

New integrative NGS panel for analysis of standard and novel biomarkers in lymphoid neoplasms

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Protein markers in chronic lymphocytic leukemia may help determine patients' prognoses

Protein markers in chronic lymphocytic leukemia may help determine patients' prognoses

Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring

Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting

Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting

Machine learning technique detects epigenetic drivers of cancers

Machine learning technique detects epigenetic drivers of cancers

New NCCN patient guidelines on anemia and neutropenia published

New NCCN patient guidelines on anemia and neutropenia published